• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

PLoS One . Fraction of plasma exomeres and low-density lipoprotein cholesterol as a predictor of fatal outcome of COVID-19

tetano

Editor, Senior Moderator
PLoS One


. 2023 Feb 9;18(2):e0278083.
doi: 10.1371/journal.pone.0278083. eCollection 2023.
Fraction of plasma exomeres and low-density lipoprotein cholesterol as a predictor of fatal outcome of COVID-19


Tatiana Usenko[SUP] 1 2 3 [/SUP], Valentina Miroshnikova[SUP] 1 2 [/SUP], Anastasia Bezrukova[SUP] 1 [/SUP], Katerina Basharova[SUP] 1 [/SUP], Sergey Landa[SUP] 1 2 [/SUP], Zoia Korobova[SUP] 4 [/SUP], Natalia Liubimova[SUP] 4 [/SUP], Ivan Vlasov[SUP] 5 [/SUP], Mikhael Nikolaev[SUP] 1 2 [/SUP], Artem Izyumchenko[SUP] 1 [/SUP], Elena Gavrilova[SUP] 2 [/SUP], Irina Shlyk[SUP] 2 [/SUP], Elena Chernitskaya[SUP] 2 [/SUP], Yurii Kovalchuk[SUP] 2 [/SUP], Petr Slominsky[SUP] 5 [/SUP], Areg Totolian[SUP] 4 [/SUP], Yurii Polushin[SUP] 2 [/SUP], Sofya Pchelina[SUP] 1 2 3 [/SUP]



Affiliations

Abstract

Transcriptomic analysis conducted by us previously revealed upregulation of genes involved in low-density lipoprotein particle receptor (LDLR) activity pathway in lethal COVID-19 caused by SARS-CoV-2 virus (severe acute respiratory syndrome coronavirus 2). Last data suggested the possible role of extracellular vesicles in COVID-19 pathogenesis. The aim of the present study was to retrospectively evaluate parameters of cholesterol metabolism and newly identified EVs, exomeres, as possible predictors of fatal outcome of COVID-19 patients infected by the Alpha and the Delta variants of SARS-CoV-2 virus. Blood from 67 patients with severe COVID-19 were collected at the time of admission to the intensive care unit (ICU) and 7 days after admission to the ICU. After 30 days patients were divided into two subgroups according to outcome-34 non-survivors and 33 survivors. This study demonstrated that plasma low- and high-density lipoprotein cholesterol levels (LDL-C and HDL-C) were decreased in non-survivors compared to controls at the time of admission to the ICU. The conjoint fraction of exomeres and LDL particles measured by dynamic light scattering (DLS) was decreased in non-survivors infected by the Alpha and the Delta variants compared to survivors at the time of admission to the ICU. We first showed that reduction of exomeres fraction may be critical in fatal outcome of COVID-19.
 
Back
Top Bottom